{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:22:18Z","timestamp":1790396538419,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","award":["R01-AI124182"],"award-info":[{"award-number":["R01-AI124182"]}],"id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","award":["R01-AI143185"],"award-info":[{"award-number":["R01-AI143185"]}],"id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","award":["R01-AI149487"],"award-info":[{"award-number":["R01-AI149487"]}],"id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.coi.2021.03.011","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T16:19:11Z","timestamp":1618330751000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs"],"prefix":"10.1016","volume":"72","author":[{"given":"Hydar","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2021.03.011_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.23822\/EurAnnACI.1764-1489.158","article-title":"Anaphylaxis","volume":"53","author":"Bilo","year":"2021","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Yu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coi.2021.03.011_bib0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/306262a0","article-title":"Substituted ammonium ions as allergenic determinants in drug allergy","volume":"306","author":"Baldo","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.03.011_bib0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2011.03.003","article-title":"Anaphylaxis during anesthesia in France: an 8-year national survey","volume":"128","author":"Mertes","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","article-title":"The pathophysiology of anaphylaxis","volume":"140","author":"Reber","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_sbref0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat1479","article-title":"An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis","volume":"11","author":"Jonsson","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2021.03.011_sbref0035","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2018.09.034","article-title":"Rocuronium hypersensitivity: does off-target occupation of the MRGPRX2 receptor play a role?","volume":"7","author":"Van Gasse","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coi.2021.03.011_bib0040","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaip.2018.01.004","article-title":"In vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature","volume":"6","author":"Ebo","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coi.2021.03.011_bib0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11882-020-00980-y","article-title":"Approach to perioperative anaphylaxis in 2020: updates in diagnosis and management","volume":"21","author":"Kalangara","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.coi.2021.03.011_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.03.011_bib0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000335614","article-title":"Etiology and pathogenesis of adverse drug reactions","volume":"97","author":"Hausmann","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.coi.2021.03.011_bib0060","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/mai.2002.123302","article-title":"Pathways of anaphylaxis in the mouse","volume":"109","author":"Strait","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603050","article-title":"IgE and IgG antibodies as regulators of mast cell and basophil functions in food allergy","volume":"11","author":"Kanagaratham","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/all.12083","article-title":"Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation","volume":"68","author":"Krause","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2021.03.011_bib0075","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1213\/00000539-198306000-00003","article-title":"Life-threatening anaphylactoid reactions to muscle relaxants","volume":"62","author":"Fisher","year":"1983","journal-title":"Anesth Analg"},{"key":"10.1016\/j.coi.2021.03.011_bib0080","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2125.2011.03913.x","article-title":"Peri-operative anaphylaxis","volume":"71","author":"Nel","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coi.2021.03.011_sbref0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.immuni.2020.01.012","article-title":"Human mast cell proteome reveals unique lineage, putative functions, and structural basis for cell ablation","volume":"52","author":"Plum","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.03.011_bib0090","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1182\/blood-2013-02-483792","article-title":"Redefinition of the human mast cell transcriptome by deep-CAGE sequencing","volume":"123","author":"Motakis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.03.011_bib0095","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0100","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ni.3445","article-title":"Expression profiling of constitutive mast cells reveals a unique identity within the immune system","volume":"17","author":"Dwyer","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0105","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/all.14252","article-title":"Surface expression of MRGPRX2 on resting basophils: an area of controversy","volume":"75","author":"Sabato","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2021.03.011_sbref0110","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/all.14213","article-title":"The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: expression and function","volume":"75","author":"Wedi","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2021.03.011_bib0115","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1111\/all.14446","article-title":"Reply to Sabato V et al. \"Surface expression of MRGPRX2 expression on resting basophils: an area of controversy\"","volume":"75","author":"Wedi","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2021.03.011_sbref0120","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jid.2020.06.030","article-title":"MRGPRX2 activation causes increased skin reactivity in patients with chronic spontaneous urticaria","volume":"141","author":"Shtessel","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2021.03.011_bib0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-0716-0696-4_18","article-title":"Measurement and functional analysis of the mas-related G protein-coupled receptor MRGPRX2 on human mast cells and basophils","volume":"2163","author":"Elst","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.coi.2021.03.011_bib0130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.intimp.2018.07.020","article-title":"Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2","volume":"62","author":"Che","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coi.2021.03.011_bib0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cellimm.2018.08.005","article-title":"Mivacurium induce mast cell activation and pseudo-allergic reactions via MAS-related G protein coupled receptor-X2","volume":"332","author":"Che","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0145","first-page":"1","article-title":"MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: modulation by sugammadex","volume":"00","author":"Fernandopulle","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2021.03.011_sbref0150","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1016\/j.bja.2020.05.046","article-title":"Association between mutated Mas-related G protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis","volume":"125","author":"Suzuki","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.coi.2021.03.011_bib0155","first-page":"679","article-title":"MRGPRX2, pseudo-allergies reloaded: a step forward and two backwards","volume":"16","author":"Spoerl","year":"2020","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.coi.2021.03.011_bib0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000446182","article-title":"Non-IgE-dependent hypersensitivity to rocuronium reversed by sugammadex: report of three cases and hypothesis on the underlying mechanism","volume":"169","author":"Spoerl","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061223","article-title":"Reclassifying anaphylaxis to neuromuscular blocking agents based on the presumed patho-mechanism: IgE-mediated, pharmacological adverse reaction or \"innate hypersensitivity\"?","volume":"18","author":"Spoerl","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2021.03.011_bib0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navines-Ferrer","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2021.03.011_bib0175","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.bja.2020.10.006","article-title":"Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity","volume":"126","author":"Ebo","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.coi.2021.03.011_bib0180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12871-017-0350-2","article-title":"The efficacy and safety of mivacurium in pediatric patients","volume":"17","author":"Zeng","year":"2017","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.coi.2021.03.011_bib0185","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00000542-200109000-00019","article-title":"Different patterns of mast cell activation by muscle relaxants in human skin","volume":"95","author":"Koppert","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coi.2021.03.011_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.anes.0000270721.27309.b3","article-title":"Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers","volume":"107","author":"Mertes","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coi.2021.03.011_bib0195","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF01988720","article-title":"Wheal and flare responses to muscle relaxants in humans","volume":"34","author":"Levy","year":"1991","journal-title":"Agents Actions"},{"key":"10.1016\/j.coi.2021.03.011_bib0200","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000542-200004000-00026","article-title":"Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells","volume":"92","author":"Veien","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coi.2021.03.011_bib0205","first-page":"623","article-title":"The lack of histamine release with cisatracurium: a double-blind comparison with vecuronium","volume":"84","author":"Doenicke","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1016\/j.coi.2021.03.011_bib0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000542-199607000-00023","article-title":"Comparative pharmacology of cisatracurium (51W), atracurium, and five isomers in cats","volume":"85","author":"Wastila","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coi.2021.03.011_bib0215","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00000539-200111000-00043","article-title":"Anaphylactoid reactions after cisatracurium administration in six patients","volume":"93","author":"Krombach","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.coi.2021.03.011_bib0220","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1515\/med-2020-0126","article-title":"Severe anaphylactic reaction to cisatracurium during anesthesia with cross-reactivity to atracurium","volume":"15","author":"Linauskiene","year":"2020","journal-title":"Open Med (Wars)"},{"key":"10.1016\/j.coi.2021.03.011_bib0225","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/all.13456","article-title":"Neuromuscular blocking agents induced anaphylaxis: results and trends of a French pharmacovigilance survey from 2000 to 2012","volume":"73","author":"Petitpain","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2021.03.011_bib0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ALN.0000000000000512","article-title":"Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium","volume":"122","author":"Reddy","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coi.2021.03.011_bib0235","article-title":"MRGPRX2 and immediate drug hypersensitivity: insights from cultured human mast cells","volume":"0","author":"Elst","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0240","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","article-title":"In silico design of novel probes for the atypical opioid receptor MRGPRX2","volume":"13","author":"Lansu","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.coi.2021.03.011_bib0245","first-page":"1","article-title":"Minireview: mas-related G protein-coupled receptor X2 activation by therapeutic drugs","volume":"135746","author":"McNeil","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.coi.2021.03.011_sbref0250","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010156","article-title":"MRGPRX2 activation by rocuronium: insights from studies with human skin mast cells and missense variants","volume":"10","author":"Chompunud Na Ayudhya","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.coi.2021.03.011_bib0255","first-page":"266","article-title":"A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host","volume":"41","author":"Bom","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.coi.2021.03.011_bib0260","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.jaci.2017.05.046","article-title":"A single amino acid in MRGPRX2 necessary for binding and activation by pruritogens","volume":"140","author":"Reddy","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0265","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4049\/jimmunol.1701793","article-title":"Naturally occurring missense MRGPRX2 variants display loss of function phenotype for mast cell degranulation in response to substance p, hemokinin-1, human beta-defensin-3, and icatibant","volume":"201","author":"Alkanfari","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0270","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1016\/j.bja.2020.08.035","article-title":"Association between mutated Mas-related G protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis","volume":"125","author":"Elst","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.coi.2021.03.011_bib0275","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.03.011_bib0280","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from The European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2021.03.011_bib0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.coi.2021.03.011_bib0290","article-title":"MRGPRX2 is the codeine receptor of human skin mast cells: desensitization through beta-arrestin and lack of correlation with the FcepsilonRI pathway","author":"Babina","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2021.03.011_bib0295","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/all.13301","article-title":"Allergic FcepsilonRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF","volume":"73","author":"Babina","year":"2018","journal-title":"Allergy"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:47:03Z","timestamp":1760604423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791521000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":59,"alternative-id":["S0952791521000315"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2021.03.011","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2021.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}